Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| AU565 | GSK2334470 | 0.1 | 0.8365 | 0.01482 |
| AU565 | GSK2334470 | 0.1 | 0.8926 | 0.00750 |
| AU565 | GSK2334470 | 0.1 | 0.9290 | -0.00092 |
| AU565 | GSK2334470 | 0.316227766 | 0.7191 | 0.00404 |
| AU565 | GSK2334470 | 0.316227766 | 0.8402 | 0.01756 |
| AU565 | GSK2334470 | 0.316227766 | 0.6799 | -0.00413 |
| AU565 | GSK2334470 | 1.0 | 0.6415 | 0.02048 |
| AU565 | GSK2334470 | 1.0 | 0.5698 | 0.02803 |
| AU565 | GSK2334470 | 1.0 | 0.6740 | 0.02364 |
| AU565 | GSK2334470 | 3.16227766 | 0.7035 | 0.01255 |
| AU565 | GSK2334470 | 3.16227766 | 0.6093 | 0.03304 |
| AU565 | GSK2334470 | 3.16227766 | 0.7983 | 0.01622 |
| AU565 | GSK2334470 | 10.0 | 0.3702 | 0.07897 |
| AU565 | GSK2334470 | 10.0 | 0.3822 | 0.03493 |
| AU565 | GSK2334470 | 10.0 | 0.4219 | 0.02227 |
| AU565 | Ribociclib | 0.001 | 0.8203 | -0.01137 |
| AU565 | Ribociclib | 0.001 | 0.7397 | 0.01023 |
| AU565 | Ribociclib | 0.001 | 0.8452 | -0.01359 |
| AU565 | Ribociclib | 0.003162278 | 0.8140 | -0.00337 |
| AU565 | Ribociclib | 0.003162278 | 0.7333 | 0.02337 |
| AU565 | Ribociclib | 0.003162278 | 0.7288 | -0.00811 |
| AU565 | Ribociclib | 0.01 | 0.6045 | 0.02511 |
| AU565 | Ribociclib | 0.01 | 0.9041 | 0.03255 |
| AU565 | Ribociclib | 0.01 | 0.5889 | 0.02553 |
| AU565 | Ribociclib | 0.031622777 | 0.6174 | 0.01176 |